Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 4
1978 2
1981 3
1983 3
1985 1
1986 1
1987 3
1988 3
1989 1
1991 4
1992 5
1993 2
1994 4
1995 3
1996 5
1997 2
1998 7
1999 8
2000 4
2001 8
2002 11
2003 7
2004 14
2005 15
2006 23
2007 31
2008 44
2009 56
2010 41
2011 45
2012 46
2013 50
2014 28
2015 38
2016 57
2017 62
2018 63
2019 75
2020 66
2021 64
2022 60
2023 52
2024 70
2025 82
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,052 results

Results by year

Filters applied: . Clear all
Page 1
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.
Landgren O, Prior TJ, Masterson T, Heuck C, Bueno OF, Dash AB, Einsele H, Goldschmidt H, Knop S, Li C, Mellqvist UH, McFadden I, Oprea C, Ross JA, Talpes M, Hydren JR, Ahlstrom JM, Kazandjian D, Weinhold N, Zhang R, Stetler-Stevenson M, Marti G, Devlin SM. Landgren O, et al. Among authors: dash ab. Blood. 2024 Jul 25;144(4):359-367. doi: 10.1182/blood.2024024371. Blood. 2024. PMID: 38768337 Free PMC article.
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group. Dimopoulos MA, et al. Among authors: dash ab. Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10. Lancet. 2019. PMID: 30545780 Clinical Trial.
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA Jr, Thompson IM. Parekh DJ, et al. Among authors: dash a. Lancet. 2018 Jun 23;391(10139):2525-2536. doi: 10.1016/S0140-6736(18)30996-6. Lancet. 2018. PMID: 29976469 Clinical Trial.
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial.
Raychaudhuri R, Khaki AR, Redman MW, Baker KK, Ng K, Chen X, Mao J, Woo B, Lin A, Hannochka A, Conrad N, Kahugu M, Panlasigui P, Haffner MC, Hsieh AC, Lam HM, Vakar-Lopez F, Yezefski T, Schweizer MT, Montgomery RB, Yu EY, Dash A, Psutka SP, Lin DW, Schade GR, Gore JL, Wright JL, Grivas P. Raychaudhuri R, et al. Among authors: dash a. Eur Urol. 2025 Aug 4:S0302-2838(25)00391-4. doi: 10.1016/j.eururo.2025.07.002. Online ahead of print. Eur Urol. 2025. PMID: 40764177
Viroimmunotherapy of Thoracic Cancers.
Dash AS, Patel MR. Dash AS, et al. Biomedicines. 2017 Jan 4;5(1):2. doi: 10.3390/biomedicines5010002. Biomedicines. 2017. PMID: 28536345 Free PMC article. Review.
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
Wright JL, Schenk JM, Gulati R, Beatty SJ, VanDoren M, Lin DW, Porter MP, Morrissey C, Dash A, Gore JL, Etzioni R, Plymate SR, Neuhouser ML. Wright JL, et al. Among authors: dash a. Cancer. 2024 Jun 15;130(12):2108-2119. doi: 10.1002/cncr.35241. Epub 2024 Feb 14. Cancer. 2024. PMID: 38353455 Free PMC article. Clinical Trial.
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myeloma.
Bruins WSC, Rentenaar R, Newcomb J, Zheng W, Ruiter RWJ, Baardemans T, Poma E, Moore C, Robinson GL, Lublinsky A, Zhang Y, Syed S, Milhollen M, Dash AB, van de Donk NWCJ, Groen RWJ, Zweegman S, Mutis T. Bruins WSC, et al. Among authors: dash ab. Hemasphere. 2024 Nov 14;8(11):e70039. doi: 10.1002/hem3.70039. eCollection 2024 Nov. Hemasphere. 2024. PMID: 39544624 Free PMC article.
1,052 results